Model Systems: Transgenic mouse models for measles pathogenesis

Trends in Microbiology

Volumn 9, Issue 1, 2001, Pages 19-23

  Manchester, Marianne ^a   Rall, Glenn R ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CELL RECEPTOR; MEMBRANE COFACTOR PROTEIN; VIRUS VACCINE;

ANTIGEN EXPRESSION; DISEASE MODEL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; MEASLES; MEASLES VIRUS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; TRANSGENIC MOUSE; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; MEASLES; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS;

ANIMALIA; MEASLES VIRUS; MUS MUSCULUS; RNA VIRUSES;

EID: 0035012262     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01903-X     Document Type: Review

References (20)

1. Naniche, D. et al. (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67, 6025-6032
2. Dorig, R. et al. ( 1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305
3. Manchester, M. et al. (2000) Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74, 3967-3974
4. Manchester, M. et al. (2000) CD46 as a measles receptor: form follows function. Virology 274, 5-10
5. Tatsuo, H. et al. (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897
6. Tangye, S.G. et al. (2000) The CD-2 subset of the Igsuperfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin. Immunol. 12, 149-157
7. Horvat, B. et al. (1996) Transgenic mice expressing human measles virus (MV) receptor provide cells exhibiting different permissivities to MV infection. J. Virol. 70, 6673-6681
8. Rail, G.F. et al. (1997) A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. U. S. A. 94, 4659-4663
9. Niewiesk, S. et al. ( 1997) CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J. Virol. 71, 7969-7973
10. Blixenkrone-Muller, U. et al. (1998) Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249, 238-248
11. Oldstone, M.B.A. et al.( 1999) Measles virus infection in a transgenic model: virus-induced central nervous system disease and immunosuppression. Cell 98, 629-640
12. Manchester, M. et al. ( 1999) Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice. J. Neuroimmunol. 96, 207-217
13. Lawrence, D.M.P. et al. (1999) Immune-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J. Virol. 73, 1795-1801
14. Evlashev, A. et al. (2000) Productive measles virus brain infection and apoptosis in CD46 transgenic mice. J. Virol. 74, 1373-1382
15. Lawrence, D.M. et al. (2000) Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation or extracellular virus production. J. Virol. 74, 1908-1918
16. Mrkic, B. et al. ( 1998) Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72, 7420-7427
17. Mrkic, B. el al. (2000) Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74, 1364-1372
18. Patterson, J.B. et al. (2000) V and C proteins of measles virus function as virulence factors in vivo. Virology 267, 80-89
19. Maisner, A. et al. (2000) Recombinant measles virus requiring an exogenous protease for activation of infectivity. J. Gen. Virol. 81, 441-449
20. Cathomen, T. et al. ( 1998) A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17, 3899-3908